Page last updated: 2024-08-23

substance p and Migraine Disorders

substance p has been researched along with Migraine Disorders in 57 studies

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	9 (15.79)	18.7374
1990's	18 (31.58)	18.2507
2000's	11 (19.30)	29.6817
2010's	16 (28.07)	24.3611
2020's	3 (5.26)	2.80

Authors

Authors	Studies
Domitrz, I; Kępczyńska, K	1
Du, XX; Feng, WX; He, JN; Wang, D; Wang, Q; Xiong, X; Zhang, H	1
Ankarali, S; Dagistan, Y; Kilinc, E; Torun, IE	1
Edvinsson, L; Fulop, F; Lukacs, M; Tajti, J; Toldi, J; Vecsei, L	1
Demartini, C; Francesconi, O; Greco, R; Nativi, C; Tassorelli, C; Tonsi, G; Zanaboni, AM	1
Ramachandran, R	1
Cui, HF; Geng, W; Han, J; Wang, CC; Wang, MM; Yang, DH; Yu, XH	1
Coveñas, R; Muñoz, M	1
Boccaletti, R; Boi, M; Cianchetti, C; Del Fiacco, M; Melis, T; Quartu, M; Serra, MP; Shevel, E	1
Silberstein, SD	1
Csáti, A; Majláth, Z; Szok, D; Tajti, J; Tuka, B; Vécsei, L	1
Sakai, F	1
Ji, CF; Jing, XH; Li, JH; Qiu, EC; Shang, HY; Shi, H; Wang, JJ	1
Chung, JW; Chung, SC; Jang, MU; Kho, HS; Park, JW	1
de Hoon, JN; Vanmolkot, FH	1
Fan, Z; Han, Y; Li, J; Liu, W; Wang, H; Xiong, W; Zhu, X	1
Fischer, MJ; Lennerz, JK; Messlinger, K	2
Chen, X; Dong, Z; Li, Z; Liang, J; Liu, R; Wang, X; Yu, S	1
Csáti, A; Kuris, A; Lukács, M; Majláth, Z; Szok, D; Tajti, J; Tuka, B; Vécsei, L	1
Diener, HC	1
Deng, G; Li, W; Li, X; Liu, W; Liu, Y; Wang, S; Wen, L; Zhong, G	1
Fusayasu, E; Iitsuka, T; Ohno, K; Saito, Y; Takeshima, T	1
Fusayasu, E; Kowa, H; Nakashima, K; Nakaso, K; Takeshima, T	1
Moskowitz, MA	2
Bruyn, GW	1
Beal, MF; Landis, DM; Marshall, PE; Martin, JB; Sagar, SM	1
Ekman, R; Fahrenkrug, J; Friberg, L; Karle, A; Olesen, J; Olsen, TS	1
Garret, C; Le Prado, N; Moussaoui, SM; Philippe, L	1
Jensen, K	1
Codini, M; Floridi, A; Franceschini, M; Gallai, V; Glioti, G; Palumbo, R; Sarchielli, P; Trequattrini, A	1
Marukawa, H; Shimomura, T; Takahashi, K	1
Shimomura, T	1
Beattie, DT; Connor, HE; Hagan, RM	1
Edvinsson, L; Olesen, J	1
Hargreaves, RJ; Hill, RG; Shepheard, SL; Williamson, DJ	1
Aubineau, P; Delépine, L	1
Bax, WA; De Vries, P; Heiligers, JP; Maassen VanDenBrink, A; Saxena, PR; Yocca, FD	1
Buckingham, JC; Kennard, C; Rhodes, KF	1
Averbeck, B; Ebersberger, A; Messlinger, K; Reeh, PW	1
Sjaastad, O; White, LR	1
Priestley, JV; Wotherspoon, G	1
Austermann, K; Göbel, H; Heinze, A; Heinze-Kuhn, K	1
Goadsby, PJ; May, A	1
Edvinsson, L; Tajti, J; Uddman, R	1
Hill, R; Ma, QP; Sirinathsinghji, D	1
Melamed, E; Moskowitz, MA; Pettibone, DJ; Reinhard, JF; Romero, J	1
Buzzi, MG; Moskowitz, MA	1
Del Bianco, E; Nicolodi, M	1
Edvinsson, L; Ekman, R; Goadsby, PJ	1
Ferrer, S	1
Sicuteri, F	1
Welch, KM	1
Hardebo, JE; Owman, C	1
Henrikson, BM; Markowitz, S; Moskowitz, MA	1
Geppetti, P; Renzi, D; Sicuteri, F	1

Reviews

20 review(s) available for substance p and Migraine Disorders

Article	Year
Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches. Toxins, 2022, 09-05, Volume: 14, Issue:9 Topics: Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Glutamates; Headache; Humans; Migraine Disorders; Neuromuscular Agents; Quality of Life; SNARE Proteins; Substance P; Tension-Type Headache; Treatment Outcome	2022
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects. Current medicinal chemistry, 2017, Volume: 24, Issue:33 Topics: Animals; Calcitonin Gene-Related Peptide; Drug Discovery; Humans; Kynurenic Acid; Migraine Disorders; Molecular Targeted Therapy; Neurogenic Inflammation; Pituitary Adenylate Cyclase-Activating Polypeptide; Substance P; Vasoactive Intestinal Peptide	2017
Neurogenic inflammation and its role in migraine. Seminars in immunopathology, 2018, Volume: 40, Issue:3 Topics: Calcitonin Gene-Related Peptide; Humans; Migraine Disorders; Neurogenic Inflammation; Neurons; Substance P	2018
Involvement of substance P and the NK-1 receptor in human pathology. Amino acids, 2014, Volume: 46, Issue:7 Topics: Alcoholism; Animals; Bacterial Infections; Depression; Humans; Inflammation; Migraine Disorders; Neoplasms; Pain; Receptors, Neurokinin-1; Seizures; Stress, Psychological; Substance P; Virus Diseases; Vomiting	2014
Migraine and neuropeptides. Neuropeptides, 2015, Volume: 52 Topics: Animals; Brain; Calcitonin Gene-Related Peptide; Humans; Migraine Disorders; Neurons; Neuropeptide Y; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Substance P; Trigeminal Ganglion; Vasoactive Intestinal Peptide	2015
[Migrainology learned from patients]. Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:11 Topics: Brain Stem; Calcitonin Gene-Related Peptide; Communication; Exercise Therapy; Humans; Hypothalamus; Intracellular Signaling Peptides and Proteins; Medical Records; Migraine Disorders; Monitoring, Physiologic; Neuropeptides; Orexins; Substance P; Trigeminal Nerve; Tryptamines	2008
[Neuropeptide effects on the trigeminal system: pathophysiology and clinical significance for migraine]. Schmerz (Berlin, Germany), 2011, Volume: 25, Issue:4 Topics: Afferent Pathways; Animals; Calcitonin Gene-Related Peptide; Cluster Headache; Disease Models, Animal; Humans; Migraine Disorders; Nociceptors; Rats; Receptors, Calcitonin Gene-Related Peptide; Signal Transduction; Substance P; Synaptic Transmission; Trigeminal Ganglion; Trigeminal Nerve; Trigeminal Nucleus, Spinal; Vasoactive Intestinal Peptide	2011
Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. The Keio journal of medicine, 2011, Volume: 60, Issue:3 Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Dura Mater; Humans; Membrane Potentials; Migraine Disorders; Neurokinin A; Neuropeptide Y; Piperazines; Quinazolines; Receptors, Calcitonin Gene-Related Peptide; Substance P; Trigeminal Ganglion; Trigeminal Nucleus, Spinal; Vasoactive Intestinal Peptide	2011
[Botulinum neurotoxin--a therapy in migraine]. Ideggyogyaszati szemle, 2012, Mar-30, Volume: 65, Issue:3-4 Topics: Acute Disease; Analgesics; Botulinum Toxins, Type A; Calcitonin Gene-Related Peptide; Chronic Disease; Clinical Trials, Phase III as Topic; Glutamic Acid; Humans; Migraine Disorders; SNARE Proteins; Substance P; Synaptosomal-Associated Protein 25; Treatment Outcome	2012
Pathophysiology of headache--past and present. Headache, 2007, Volume: 47 Suppl 1 Topics: Cortical Spreading Depression; Headache; History, 20th Century; History, 21st Century; Humans; Migraine Disorders; Neurotransmitter Agents; Receptors, Calcitonin Gene-Related Peptide; Substance P; Synapses; Trigeminal Nerve	2007
The biochemistry of migraine. Headache, 1980, Volume: 20, Issue:5 Topics: Brain Chemistry; Histamine; Humans; Hypothalamus; Kinins; Migraine Disorders; Prostaglandins; Serotonin; Substance P; Tyramine	1980
Implications of neuropeptides in neurological diseases. Peptides, 1984, Volume: 5 Suppl 1 Topics: Alzheimer Disease; Animals; Brain; Cholecystokinin; Choline O-Acetyltransferase; Endorphins; Epilepsy; Forecasting; Histocytochemistry; Humans; Huntington Disease; Migraine Disorders; Nerve Tissue Proteins; Nervous System Diseases; Pain; Parkinson Disease; Radioimmunoassay; Somatostatin; Substance P; Thyrotropin-Releasing Hormone; Tissue Distribution; Vasopressins	1984
Extracranial blood flow, pain and tenderness in migraine. Clinical and experimental studies. Acta neurologica Scandinavica. Supplementum, 1993, Volume: 147 Topics: Female; Humans; Kinins; Male; Meningeal Arteries; Migraine Disorders; Muscles; Neck Muscles; Neuropeptides; Nociceptors; Pain Threshold; Palpation; Skull; Substance P; Temporal Arteries; Temporal Muscle; Trigeminal Nerve	1993
[Tension-type headache: 5-hydroxytryptamine and related substances]. Rinsho shinkeigaku = Clinical neurology, 1995, Volume: 35, Issue:12 Topics: Blood Platelets; Humans; Migraine Disorders; Mitochondria; Neurotransmitter Agents; Norepinephrine; Point Mutation; Serotonin; Substance P; Superoxide Dismutase; Tension-Type Headache	1995
Recent developments in tachykinin NK1 receptor antagonists: prospects for the treatment of migraine headache. Canadian journal of physiology and pharmacology, 1995, Volume: 73, Issue:7 Topics: Brain; Brain Edema; Humans; Migraine Disorders; Neurokinin-1 Receptor Antagonists; Substance P; Vasodilation	1995
[Botulinum toxin A for the treatment of headache disorders and pericranial pain syndromes]. Der Nervenarzt, 2001, Volume: 72, Issue:4 Topics: Analgesics, Non-Narcotic; Botulinum Toxins, Type A; Clinical Trials as Topic; Cluster Headache; Dystonic Disorders; Facial Neuralgia; Germany; Headache Disorders; Humans; Migraine Disorders; Muscle, Skeletal; Myofascial Pain Syndromes; Neck Pain; Neuromuscular Agents; Practice Guidelines as Topic; Substance P	2001
Pharmacological opportunities and pitfalls in the therapy of migraine. Current opinion in neurology, 2001, Volume: 14, Issue:3 Topics: Animals; Calcitonin Gene-Related Peptide; Clinical Trials as Topic; Endothelins; Humans; Migraine Disorders; Neurokinin-1 Receptor Antagonists; Serotonin Receptor Agonists; Substance P; Treatment Outcome; Vasoconstrictor Agents	2001
The trigemino-vascular system and migraine. Pathologie-biologie, 1992, Volume: 40, Issue:4 Topics: Blood Proteins; Calcitonin Gene-Related Peptide; Cerebrovascular Disorders; Cranial Nerve Diseases; Dihydroergotamine; Dura Mater; Humans; Indoles; Migraine Disorders; Receptors, Serotonin; Substance P; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents	1992
[Physiopathology of migraine]. Revista medica de Chile, 1990, Volume: 118, Issue:8 Topics: Cerebrovascular Circulation; Humans; Migraine Disorders; Substance P; Trigeminal Nerve	1990
Symptomatologic interdependence or interindependence as a key alternative in migraine and cluster headache mechanisms. Cephalalgia : an international journal of headache, 1985, Volume: 5 Suppl 2 Topics: Cluster Headache; Humans; Migraine Disorders; Nociceptors; Pain; Substance P; Vascular Headaches	1985

Trials

1 trial(s) available for substance p and Migraine Disorders

Article	Year
RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. Cephalalgia : an international journal of headache, 2003, Volume: 23, Issue:3 Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Isoindoles; Male; Middle Aged; Migraine Disorders; Substance P	2003

Other Studies

36 other study(ies) available for substance p and Migraine Disorders

Article	Year
[Effects of moxibustion on serum levels of β-EP, SP and expression of IL-1β and COX-2 protein in brainstem in rats with migraine]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2023, Feb-12, Volume: 43, Issue:2 Topics: Animals; beta-Endorphin; Brain Stem; Cyclooxygenase 2; Interleukin-1beta; Male; Migraine Disorders; Moxibustion; Rats; Rats, Sprague-Dawley; Substance P	2023
Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine. The European journal of neuroscience, 2022, Volume: 55, Issue:4 Topics: Animals; Calcitonin Gene-Related Peptide; Endocannabinoids; Male; Migraine Disorders; Neurogenic Inflammation; Nitroglycerin; Rats; Rimonabant; Substance P	2022
The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model. The journal of headache and pain, 2017, Sep-07, Volume: 18, Issue:1 Topics: Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Hyperalgesia; Male; Migraine Disorders; Nitroglycerin; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Substance P; Trigeminal Caudal Nucleus; Trigeminal Ganglion; TRPA1 Cation Channel	2017
[Effect of Manual Acupuncture Preconditioning on Behavior and Contents of Serum CGRP, SP, IL-1 β and TNF-α Levels in Migraine Rats]. Zhen ci yan jiu = Acupuncture research, 2018, Jun-25, Volume: 43, Issue:6 Topics: Acupuncture Therapy; Animals; Calcitonin; Calcitonin Gene-Related Peptide; Interleukin-1beta; Male; Migraine Disorders; Rats; Rats, Sprague-Dawley; Rats, Wistar; Substance P; Tumor Necrosis Factor-alpha	2018
TRPV1, CGRP and SP in scalp arteries of patients suffering from chronic migraine. Journal of neurology, neurosurgery, and psychiatry, 2015, Volume: 86, Issue:4 Topics: Adult; Aged; Arteries; Calcitonin Gene-Related Peptide; Female; Humans; Male; Middle Aged; Migraine Disorders; Nerve Fibers; Regional Blood Flow; Scalp; Substance P; TRPV Cation Channels; Young Adult	2015
TRPV1, CGRP and SP in scalp arteries of patients suffering from chronic migraine. Some like it hot! Chronic migraine increases TRPV1 receptors in the scalp. Journal of neurology, neurosurgery, and psychiatry, 2015, Volume: 86, Issue:4 Topics: Arteries; Calcitonin Gene-Related Peptide; Female; Humans; Male; Migraine Disorders; Scalp; Substance P; TRPV Cation Channels	2015
[Effect of electroacupuncture on cortical spreading depression and plasma CGRP and substance P contents in migraine rats]. Zhen ci yan jiu = Acupuncture research, 2010, Volume: 35, Issue:1 Topics: Animals; Calcitonin Gene-Related Peptide; Cortical Spreading Depression; Disease Models, Animal; Electroacupuncture; Humans; Male; Migraine Disorders; Random Allocation; Rats; Rats, Sprague-Dawley; Substance P	2010
Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral diseases, 2011, Volume: 17, Issue:2 Topics: Adult; Calcitonin Gene-Related Peptide; Case-Control Studies; Chronic Disease; Facial Pain; Female; Humans; Male; Migraine Disorders; Nerve Growth Factor; Neuropeptides; Pain Measurement; Saliva; Salivary Proteins and Peptides; Secretory Rate; Sex Factors; Substance P	2011
Endothelial function in migraine: a cross-sectional study. BMC neurology, 2010, Dec-01, Volume: 10 Topics: Adult; Analysis of Variance; Cross-Sectional Studies; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Forearm; Humans; Male; Migraine Disorders; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Substance P; Tissue Plasminogen Activator; Vasodilation	2010
[Heat coagulation of middle meningeal artery affects plasma CGRP and substance P levels in migraine rat triggered by nitroglycerin]. Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2011, Volume: 25, Issue:10 Topics: Animals; Calcitonin Gene-Related Peptide; Electrocoagulation; Female; Meningeal Arteries; Migraine Disorders; Nitroglycerin; Rats; Rats, Wistar; Substance P	2011
The effects of OB-induced depression on nociceptive behaviors induced by electrical stimulation of the dura mater surrounding the superior sagittal sinus. Brain research, 2011, Nov-18, Volume: 1424 Topics: Amitriptyline; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Dura Mater; Electric Stimulation; Male; Migraine Disorders; Olfactory Bulb; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P; Superior Sagittal Sinus	2011
Treatment of migraine with acupuncture at points pertaining to the liver and gallbladder channels. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2003, Volume: 23, Issue:3 Topics: Acupuncture Points; Adolescent; Adult; Aged; Calcitonin Gene-Related Peptide; Diagnosis, Differential; Electroacupuncture; Female; Follow-Up Studies; Humans; Male; Medicine, Chinese Traditional; Meridians; Middle Aged; Migraine Disorders; Substance P	2003
Familial limb pain in childhood: unusual manifestation of migraine? Brain & development, 2006, Volume: 28, Issue:10 Topics: Analgesics; Calcitonin Gene-Related Peptide; Child; Child, Preschool; Extremities; Family Health; Humans; Immunoenzyme Techniques; Male; Migraine Disorders; Pain; Substance P	2006
Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain, 2007, Volume: 128, Issue:3 Topics: Adult; Biomarkers; Calcitonin Gene-Related Peptide; Female; Humans; Male; Migraine Disorders; Peptidyl-Dipeptidase A; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Substance P	2007
The neurobiology of vascular head pain. Annals of neurology, 1984, Volume: 16, Issue:2 Topics: Afferent Pathways; Animals; Arteritis; Blood-Brain Barrier; Capillary Permeability; Cerebral Arteries; Cortical Spreading Depression; Humans; Migraine Disorders; Nerve Fibers; Neurotransmitter Agents; Nociceptors; Substance P; Trigeminal Ganglion; Trigeminal Nerve; Vascular Headaches	1984
Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura. Cephalalgia : an international journal of headache, 1994, Volume: 14, Issue:1 Topics: Adult; Calcitonin; Calcitonin Gene-Related Peptide; Carotid Artery, Internal; Cerebral Angiography; Cerebrovascular Circulation; Female; Hemiplegia; Humans; Ischemic Attack, Transient; Jugular Veins; Male; Middle Aged; Migraine Disorders; Neuropeptide Y; Neuropeptides; Paresthesia; Radionuclide Imaging; Substance P; Vasoactive Intestinal Peptide; Vision Disorders; Xenon Radioisotopes	1994
Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580. European journal of pharmacology, 1993, Jul-20, Volume: 238, Issue:2-3 Topics: Animals; Capsaicin; Dose-Response Relationship, Drug; Dura Mater; Guinea Pigs; Indoles; Inflammation; Injections, Intravenous; Isoindoles; Male; Meninges; Migraine Disorders; Rats; Rats, Wistar; Stereoisomerism; Substance P	1993
Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia : an international journal of headache, 1995, Volume: 15, Issue:5 Topics: Adolescent; Calcitonin Gene-Related Peptide; Female; Humans; Male; Migraine Disorders; Neurokinin A; Neuropeptides; Substance P	1995
Salivary substance P, 5-hydroxytryptamine, and gamma-aminobutyric acid levels in migraine and tension-type headache. Headache, 1996, Volume: 36, Issue:2 Topics: Adult; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Migraine Disorders; Saliva; Serotonin; Substance P; Tension-Type Headache	1996
Molecular aspects of headaches and migraines. 7th International Headache Research Seminar. Copenhagen, Denmark, 22-24 November 1996. Molecular medicine today, 1997, Volume: 3, Issue:5 Topics: Animals; Calcitonin Gene-Related Peptide; Cortical Spreading Depression; Disease Susceptibility; Headache; Humans; Migraine Disorders; Nitric Oxide; Second Messenger Systems; Serotonin; Substance P; Vasodilation	1997
The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation. European journal of pharmacology, 1997, Jun-05, Volume: 328, Issue:1 Topics: Analysis of Variance; Animals; Blood Proteins; Calcitonin Gene-Related Peptide; Disease Models, Animal; Dura Mater; Electric Stimulation; Injections, Intravenous; Lethal Dose 50; Male; Meningeal Arteries; Migraine Disorders; Neuromuscular Junction; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Substance P; Triazoles; Trigeminal Nuclei; Tryptamines; Vasodilation	1997
Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion. Experimental neurology, 1997, Volume: 147, Issue:2 Topics: Acetylcholine; Afferent Pathways; Animals; Atropine; Axons; Blood Pressure; Blood Proteins; Calcitonin Gene-Related Peptide; Capsaicin; Carbachol; Disease Models, Animal; Dura Mater; Electric Stimulation; Exudates and Transudates; Ganglia, Parasympathetic; Inflammation; Injections, Intra-Arterial; Male; Migraine Disorders; Neurons, Afferent; Parasympathetic Fibers, Postganglionic; Parasympathomimetics; Permeability; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Serum Albumin, Bovine; Substance P	1997
BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential. European journal of pharmacology, 1998, Jun-26, Volume: 351, Issue:3 Topics: Animals; Arteriovenous Anastomosis; Carotid Arteries; Coronary Vessels; Hemodynamics; Humans; In Vitro Techniques; Indoles; Jugular Veins; Migraine Disorders; Muscle Contraction; Muscle, Smooth, Vascular; Oxygen; Piperazines; Potassium; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Substance P; Sumatriptan; Swine; Vasoconstrictor Agents	1998
The inhibition of nicotine-evoked relaxation of the guinea-pig isolated basilar artery by some analgesic drugs and progesterone. British journal of pharmacology, 1999, Volume: 126, Issue:4 Topics: Analgesics; Animals; Aspirin; Basilar Artery; Capsaicin; Dinoprost; Guinea Pigs; In Vitro Techniques; Indomethacin; Male; Migraine Disorders; NG-Nitroarginine Methyl Ester; Nicotine; Progesterone; Substance P; Sumatriptan; Vasodilation	1999
Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience, 1999, Volume: 89, Issue:3 Topics: Afferent Pathways; Animals; Arachnoid; Bradykinin; Calcitonin Gene-Related Peptide; Dinoprostone; Dura Mater; Electric Stimulation; Headache; Histamine; Inflammation; Male; Migraine Disorders; Neurons, Afferent; Nociceptors; Organ Culture Techniques; Rats; Rats, Wistar; Serotonin; Substance P; Trigeminal Ganglion; Vasodilation	1999
Sumatriptan and sensory neuropeptide activity in subarachnoid haemorrhage: an hypothesis. Cephalalgia : an international journal of headache, 1995, Volume: 15, Issue:6 Topics: Animals; Calcitonin Gene-Related Peptide; Humans; Migraine Disorders; Subarachnoid Hemorrhage; Substance P; Sumatriptan; Vasoconstrictor Agents	1995
Expression of the 5-HT1B receptor by subtypes of rat trigeminal ganglion cells. Neuroscience, 2000, Volume: 95, Issue:2 Topics: Animals; Biomarkers; Calcitonin Gene-Related Peptide; Coloring Agents; Gene Expression; In Situ Hybridization; Lectins; Male; Migraine Disorders; Nerve Fibers, Myelinated; Neurofilament Proteins; Neurons, Afferent; Nociceptors; Plant Lectins; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, trkA; Receptors, Serotonin; RNA, Messenger; Substance P; Tolonium Chloride; Trigeminal Ganglion; Vasodilation	2000
Neuropeptide localization in the "migraine generator" region of the human brainstem. Cephalalgia : an international journal of headache, 2001, Volume: 21, Issue:2 Topics: Adult; Aged; Brain Stem; Calcitonin Gene-Related Peptide; Female; Humans; Locus Coeruleus; Male; Middle Aged; Migraine Disorders; Neuropeptide Y; Neuropeptides; Peptide Fragments; Periaqueductal Gray; Pituitary Adenylate Cyclase-Activating Polypeptide; Raphe Nuclei; Substance P; Vasoactive Intestinal Peptide	2001
Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. The European journal of neuroscience, 2001, Volume: 13, Issue:11 Topics: Animals; Calcitonin Gene-Related Peptide; Cell Size; Dura Mater; Fluorescent Antibody Technique; Meningeal Arteries; Migraine Disorders; Nerve Fibers; Nerve Fibers, Myelinated; Neurofilament Proteins; Neurons, Afferent; Nociceptors; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Substance P; Trigeminal Ganglion; Vasodilation	2001
Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet (London, England), 1979, Oct-27, Volume: 2, Issue:8148 Topics: Cerebrovascular Circulation; Humans; Migraine Disorders; Neurotransmitter Agents; Nociceptors; Serotonin; Substance P; Synaptic Transmission; Trigeminal Nerve; Vasodilator Agents	1979
Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache. Cephalalgia : an international journal of headache, 1990, Volume: 10, Issue:1 Topics: Adult; Calcitonin Gene-Related Peptide; Cluster Headache; Female; Humans; Male; Middle Aged; Migraine Disorders; Saliva; Substance P; Vascular Headaches; Vasoactive Intestinal Peptide	1990
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Annals of neurology, 1990, Volume: 28, Issue:2 Topics: Adult; Calcitonin Gene-Related Peptide; Cerebrovascular Circulation; Elbow; Female; Humans; Jugular Veins; Male; Middle Aged; Migraine Disorders; Neuropeptide Y; Neuropeptides; Substance P; Trigeminal Ganglion; Vasoactive Intestinal Peptide; Vasodilation	1990
Migraine: a biobehavioral disorder. Cephalalgia : an international journal of headache, 1986, Volume: 6 Suppl 4 Topics: Animals; Arousal; Autonomic Nervous System; Brain; Cortical Spreading Depression; Evoked Potentials; Humans; Migraine Disorders; Neural Pathways; Neurons; Norepinephrine; Prostaglandins; Substance P; Synaptic Transmission	1986
Multiple transmitter amines and peptides in cerebrovascular nerves: possible links in migraine pathophysiology. Cephalalgia : an international journal of headache, 1986, Volume: 6 Suppl 4 Topics: Adrenergic Fibers; Calcitonin Gene-Related Peptide; Cerebral Arteries; Cerebrovascular Circulation; Cholecystokinin; Cholinergic Fibers; Gastrin-Releasing Peptide; Histamine; Humans; Migraine Disorders; Muscle, Smooth, Vascular; Neuropeptide Y; Neuropeptides; Neurotransmitter Agents; Peptides; Serotonin; Substance P; Vasoactive Intestinal Peptide	1986
Experimental studies on the sensory innervation of the cerebral blood vessels. Cephalalgia : an international journal of headache, 1986, Volume: 6 Suppl 4 Topics: Animals; Cerebral Arteries; Headache; Humans; Migraine Disorders; Pia Mater; Sensory Receptor Cells; Substance P; Trigeminal Nerve	1986
Substance P and enkephalins: a creditable tandem in the pathophysiology of cluster headache and migraine. Advances in experimental medicine and biology, 1986, Volume: 198 Pt B Topics: Analgesia; Endopeptidases; Enkephalins; Histamine; Humans; Migraine Disorders; Neprilysin; Stress, Physiological; Substance P; Vascular Headaches	1986